Medicine
Oxervate kit
Oxervate kit is a prescription medicine containing Cenegermin, marketed by Domp farmaceutici, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Store the weekly cartons containing OXERVATE vials in the freezer at or below…
Key facts
- Active ingredient (INN)
- Cenegermin
- Brand
- Oxervate
- Dosage form
- Kit
- Packs
- 1 kit
- Marketing authorisation holder
- Domp farmaceutici
- Manufacturer
- Domp farmaceutici
- Origin register
- US FDA, United States
- Storage
- Store the weekly cartons containing OXERVATE vials in the freezer at or below -4°F (-20°C). Patient Storage Within 5 hours of delivery, store the weekly carton(s) containing OXERVATE vials in the refrigerator between 36°F to 46°F (2°C to 8°C) for up to 14 days.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- S01XA24 Cenegermin
- HS code (indicative)
- 3002.15Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 26 November 2018
- Identifiers
- RxCUI 2104336, 2104341DailyMed set ID 89e4bfec-d710-40ed-8885-5d13ba46b1cdNDC 71981-001Application BLA761094
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 kit in 1 kit * 7 vial, multi-dose in 1 carton / 1 mL in 1 vial, multi-dose | 71981-001-01 | Domp farmaceutici | 26 November 2018 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Cenegermin
Clinical summary
Cenegermin is a recombinant human nerve growth factor indicated for the treatment of neurotrophic keratitis. It is available as eye drops and kits for ophthalmic use. MedsAcross supplies Cenegermin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about CenegerminFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- OXERVATE prescribing information (Domp farmaceutici) · U.S. National Library of Medicine, DailyMed
- Oxervate: European public assessment report (EPAR) · European Medicines Agency
Need Oxervate kit for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.